Farther Finance Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.04M Buy
3,871
+1,278
+49% +$717K 0.02% 733
2026
Q1
$1.46M Sell
2,593
-690
-21% -$442K 0.01% 782
2025
Q4
$2.22M Sell
3,283
-182
-5% -$124K 0.02% 545
2025
Q3
$2.21M Buy
3,465
+348
+11% +$211K 0.03% 421
2025
Q2
$1.67M Buy
3,117
+1,040
+50% +$497K 0.03% 420
2025
Q1
$869K Buy
2,077
+1,440
+226% +$625K 0.02% 566
2024
Q4
$263K Sell
637
-168
-21% -$73.7K 0.01% 866
2024
Q3
$407K Buy
805
+105
+15% +$51K 0.02% 680
2024
Q2
$334K Buy
700
+305
+77% +$153K 0.02% 630
2024
Q1
$210K Buy
395
+121
+44% +$66.1K 0.01% 667
2023
Q4
$152K Buy
274
+184
+204% +$86.4K 0.01% 647
2023
Q3
$39.4K Buy
90
+40
+80% +$19.9K 0.01% 851
2023
Q2
$25.1K Buy
50
+2
+4% +$958 0.01% 921
2023
Q1
$24K Buy
48
+4
+9% +$1.91K 0.01% 841
2022
Q4
$17.9K Buy
+44
New +$17.1K 0.01% 770

Other funds holding IDXX

Farther Finance Advisors's IDXX Position: Q2 2026 in Review

Farther Finance Advisors increased its Idexx Laboratories (IDXX) stake by 49% in Q2 2026, buying an estimated $717K and bringing the position to 3,871 shares worth $2.04M. The position accounts for 0.02% of the portfolio, ranked #733.

Farther Finance Advisors first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.22M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Farther Finance Advisors held 3,871 shares of Idexx Laboratories worth $2.04M as of Q2 2026.
  • Farther Finance Advisors bought 1,278 Idexx Laboratories shares in Q2 2026, an estimated $717K.
  • Idexx Laboratories made up 0.02% of Farther Finance Advisors's portfolio in Q2 2026, its #733 holding.
  • Farther Finance Advisors first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Idexx Laboratories position peaked at $2.22M in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.